Here are three stocks with buy ranks and strong growth characteristics for investors to consider today December 19th:Twilio (TWLO) : This company which enables developers to build, scale and operate real-time communications within software applications, carries a Zacks Rank #1 (Strong Buy), and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.7% over the last 60 days.Twilio has a PEG ratio of 0.69 compared with 1.84 for the industry. The company possesses a Growth Score ...

McKesson Corporation (MCK) is well-poised for growth in the coming quarters, courtesy of its strong Biologics business. The optimism, led by a decent first-quarter fiscal 2025 performance and improving demand for healthcare, is expected to contribute further. However, stiff competition and weaker generic pharmaceutical pricing trends persist.In the past year, MCK’s shares have risen 25.6% compared with the industry’s growth of 3.5%. The S&P 500 has gained 28.3% in the same time frame.The renowned healthcare ...

For Immediate ReleaseChicago, IL – December 13, 2024 – Today, Zacks Equity Research Becton, Dickinson and Co. (BDX) , or BD, McKesson (MCK) , Cardinal Health (CAH) and Merit Medical Systems (MMSI) .Industry: Dental SuppliesLink: https://www.zacks.com/commentary/2382578/4-stocks-to-watch-amid-dental-supplies-industry-challengesThe Zacks Medical - Dental Supplies industry in the Medical sector has shown a consolidating trend in 2024 amid a rise in product sales. Although dental patient traffic remained stable ...

McKesson Corporation (NYSE:MCK) Annual Evercore ISI HealthCONx Healthcare Conference December 4, 2024 8:20 AM ET Company Participants Britt Vitalone - Executive Vice President and Chief Financial Officer Conference Call Participants Elizabeth Anderson - Evercore ISI Elizabeth Anderson Thank you for joining us this morning. Appreciate you coming by. I'm Elizabeth Anderson. I'm a health care services analyst here at Evercore. Very excited to be joined, by Britt Vitalone from McKesson. So, I think we'll get st ...

McKesson Corporation (MCK) witnessed strong momentum in the year-to-date period. Shares of the company rallied 34.1% compared with 2.9% growth of the industryin the same period. The S&P 500 Composite has risen 24.5% during the same time frame. With healthy fundamentals and strong growth opportunities, this Zacks Rank #3 (Hold) company appears to be a solid wealth creator for its investors at the moment. Headquartered in San Francisco, CA, McKesson is a healthcare services and information technology company ...

McKesson Corporation's (MCK) dedicated business focused on supporting the commercialization of cell and gene therapies, InspiroGene, has been selected by Vertex Pharmaceuticals Incorporated (VRTX) to expand commercial distribution options for CASGEVY. InspiroGene will partner with Vertex to expand distribution options for CASGEVY. CASGEVY (exagamglogene autotemcel), the first CRISPR-based gene-editing therapy approved by the FDA, is indicated for the treatment of patients 12 years and above with sickle cell ...

Investors might want to bet on McKesson (MCK) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years. Individual inv ...

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though?Let's take a look at what these Wall Street heavyweights have to say about McKesson (MCK) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.McKesson currently has an average ...

McKesson (MCK) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the past month, shares of this prescription drug distributor have returned +20.3%, compared to the Zacks S&P 500 composite's +3% change. During this period, the Zacks Medical - Dental Supplies industry, which McKesson falls in, has gained 7%. The key question now is: What could be the stock's future direction? While m ...

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a great growth stock is not easy at all.That's because, these stocks usually carry above-average risk and volatility. In fact, betting on a stock for which the growth story is actually over or nearing its end could lead to significant loss.However, it's pretty easy to find cutting-edge growth stocks with the help of the Zacks Gro ...